[Skip to Content]
[Skip to Content Landing]
Views 560
Citations 0
Comment & Response
November 15, 2018

Inconsistent Reporting of Potential Conflicts of Interest in JAMA

Author Affiliations
  • 1Duke–Robert J. Margolis Center for Health Policy, Duke University, Durham, North Carolina
JAMA. Published online November 15, 2018. doi:10.1001/jama.2018.18490

To the Editor I am writing to provide additional information regarding my conflict of interest disclosures in articles I published in JAMA between 2014 and 2018. In my previous reporting, I included disclosures of potential conflicts of interest that seemed “reasonably related” to the topic of the article, as suggested in ICJME guidance. Consequently, I included my status as an independent board member of Johnson & Johnson in articles that focused on drug or device payment or regulation, and I included my activities related to accountable care organizations and other specific provider payment reforms in articles that focused on those topics.1-4 These activities are publicly known. To promote transparency, I also provide information on my activities on my web page.5

For completeness and to avoid confusion, I requested a reporting adjustment to make reporting of conflict of interest disclosures consistent in my prior articles and with when the activities began.

For each of these articles,6-9 my disclosure statement should have read as follows: “Dr McClellan reports earning fees as an independent board member for Johnson & Johnson and Alignment Health Care, and co-chairing the Accountable Care Learning Collaborative and the Guiding Committee for the Health Care Payment Learning and Action Network.” For each of these articles,10-12 my disclosure statement should have read as follows: “Dr McClellan reports earning fees as an independent board member for Johnson & Johnson.”

I regret any confusion this has caused and have requested that these articles be corrected online.13

Section Editor: Jody W. Zylke, MD, Deputy Editor.
Back to top
Article Information

Corresponding Author: Mark B. McClellan, MD, PhD, Duke–Robert J. Margolis Center for Health Policy, Duke University, 100 Fuqua Dr, Box 90120, Durham, NC 27708 (mark.mcclellan@duke.edu).

Published Online: November 15, 2018. doi:10.1001/jama.2018.18490

Conflict of Interest Disclosures: Dr McClellan reports earning fees as an independent board member for Johnson & Johnson and Alignment Health Care; co-chairing the Accountable Care Learning Collaborative and the Guiding Committee for the Health Care Payment Learning and Action Network; and currently receives fees as an advisor to Cota, MITRE, and the National Institute for Health Care Management.

References
1.
Dzau  VJ, McClellan  MB, McGinnis  JM,  et al.  Vital directions for health and health care: priorities from a National Academy of Medicine initiative.  JAMA. 2017;317(14):1461-1470. doi:10.1001/jama.2017.1964PubMedGoogle ScholarCrossref
2.
Feinberg  DT, McClellan  MB.  More value from payment reform in health care and biomedical innovation.  JAMA. 2016;316(16):1653-1654. doi:10.1001/jama.2016.14670PubMedGoogle ScholarCrossref
3.
McClellan  MB, Leavitt  MO.  Competencies and tools to shift payments from volume to value.  JAMA. 2016;316(16):1655-1656. doi:10.1001/jama.2016.14205PubMedGoogle ScholarCrossref
4.
Clough  JD, McClellan  M.  Implementing MACRA: implications for physicians and for physician leadership.  JAMA. 2016;315(22):2397-2398. doi:10.1001/jama.2016.7041PubMedGoogle ScholarCrossref
5.
Duke Margolis Center for Health Policy. Mark McClellan, MD, PhD. https://healthpolicy.duke.edu/mark-mcclellan-md-phd. Accessed October 22, 2018.
6.
Nussbaum  S, McClellan  M, Metlay  G.  Principles for a framework for alternative payment models.  JAMA. 2018;319(7):653-654. doi:10.1001/jama.2017.20226PubMedGoogle ScholarCrossref
7.
Daniel  GW, Schneider  M, McClellan  MB.  Addressing antimicrobial resistance and stewardship: the Priority Antimicrobial Value and Entry (PAVE) Award.  JAMA. 2017;318(12):1103-1104. doi:10.1001/jama.2017.10164PubMedGoogle ScholarCrossref
8.
Shrank  WH, Saunders  RS, McClellan  M.  Better evidence to guide payment reforms: recognizing the importance of perspective.  JAMA. 2017;317(8):805-806. doi:10.1001/jama.2017.0034PubMedGoogle ScholarCrossref
9.
Dzau  VJ, McClellan  M, McGinnis  JM.  Vital directions for health and health care: an initiative of the National Academy of Medicine.  JAMA. 2016;316(7):711-712. doi:10.1001/jama.2016.10692PubMedGoogle ScholarCrossref
10.
McClellan  M.  Accountable care organizations and evidence-based payment reform.  JAMA. 2015;313(21):2128-2130. doi:10.1001/jama.2015.5087PubMedGoogle ScholarCrossref
11.
Mostashari  F, Sanghavi  D, McClellan  M.  Health reform and physician-led accountable care: the paradox of primary care physician leadership.  JAMA. 2014;311(18):1855-1856. doi:10.1001/jama.2014.4086PubMedGoogle ScholarCrossref
12.
McClellan  M, Patel  K, Sanghavi  D.  Medicare physician payment reform: will 2014 be the fix for SGR?  JAMA. 2014;311(7):669-670. doi:10.1001/jama.2013.286100PubMedGoogle ScholarCrossref
13.
Incorrect conflict of interest disclosure [correction].  JAMA. doi:10.1001/jama.2018.18875
×